[Clinical study on acute upper respiratory tract infection treated with qingkailing injection].
To explore the effect of Qingkailing injection (QKLI) in treating acute fever. Four hundred cases of acute upper respiratory tract infection were divided into three groups treated with QKLI 120 ml/d, 160 ml/d and 200 ml/d respectively, and compared with a control group treated with lincomycin 1.8 g/d. The markedly effective rate of QKLI was 84.14% which was better than that of lincomycin (75.83%). The mean initial time of QKLI (12.6 h) was shorter than that of lincomycin (17.6 h). Effect of QKLI on patients with disease course within one day was better than that within 3 days. No significant difference revealed between effects in groups treated with different dosage of QKLI. The effect of QKLI in lowering white blood cell count was similar to that of lincomycin. For patients with positive throat swab culture of pathogenic bacteria, QKLI displayed good antibacterial action in vivo. QKLI is a highly effective with rapid action drug for treatment of acute respiratory infection.